Zimbabwe has turned down a major US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years because of the United States' demand for confidential information.
This move became public following a official document dated December was leaked, which showed President Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesman later clarified that the US was demanding access to health data for scientific study and profit but was unwilling to share the resulting advantages from any future medical innovations.
"We must now begin the challenging and unfortunate task of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated over $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for continued negotiations to find a deal suitable to all parties so the country's critical HIV treatment initiative can continue.
Broader Background
Zimbabwe's decision comes after a comparable case in Kenya, where a high court suspended a related deal with the US following legal challenges were filed about the safety of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
USAID had overseen aid for the American government, but Trump claimed its spending was "inefficient" and his administration was seeking government-to-government agreements to boost transparency and responsibility.
As per reports, Sixteen nations in Africa have so far agreed to these new health pacts, constituting more than $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million currently on HIV treatment via US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information over an extended period, without any corresponding promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"In essence, our country would supply the raw materials for medical research without any assurance that the end products would be accessible to our citizens if a future pandemic arise."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining structures already established through the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to manage future pandemics.
"This framework is intended to guarantee that when a country contributes its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome further discussions with our American counterparts on how subsequent collaboration could be structured in a manner that respects the sovereignty and interests of both nations."
Medical Community Reaction
Medical experts expressed it understood the official position, but urged that negotiations should continue since a large portion of the nation's Aids initiatives were funded by international support.
"If technical issues arise, such as those relating to information security or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," it said.
The situation highlights the continuing debate between receiving much-needed foreign assistance and protecting a country's data in an ever more interconnected world.